Split History
ETFs Holding REPH »    REPH Historical Stock Prices »
Video: What is a Stock Split?


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Recro Pharma is a contract development and manufacturing organization, solving formulation and manufacturing challenges primarily in small molecule therapeutic development. Co. utilizes its formulation and development knowledge to develop and manufacture pharmaceutical products using proprietary delivery technologies and know-how for partners who develop and commercialize or plan to commercialize these products. Co. has launched its clinical trials support services capabilities, which includes preparation of clinical trial supplies, as well as services dedicated to the development and Good Manufacturing Practices, of high-potency products. According to our REPH split history records, REPH has had 1 split.
REPH split history picture
REPH (REPH) has 1 split in our REPH split history database. The split for REPH took place on November 22, 2019. This was a 1115 for 1000 split, meaning for each 1000 shares of REPH owned pre-split, the shareholder now owned 1115 shares. For example, a 1000 share position pre-split, became a 1115 share position following the split.

When a company such as REPH splits its shares, the market capitalization before and after the split takes place remains stable, meaning the shareholder now owns more shares but each are valued at a lower price per share. Often, however, a lower priced stock on a per-share basis can attract a wider range of buyers. If that increased demand causes the share price to appreciate, then the total market capitalization rises post-split. This does not always happen, however, often depending on the underlying fundamentals of the business.

Looking at the REPH split history from start to finish, an original position size of 1000 shares would have turned into 1115 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into REPH shares, starting with a $10,000 purchase of REPH, presented on a split-history-adjusted basis factoring in the complete REPH split history. REPH split adjusted history picture

Growth of $10,000.00
With Dividends Reinvested

Start date: 03/10/2014
End date: 03/21/2022
Start price/share: $7.57
End price/share: $2.09
Starting shares: 1,321.00
Ending shares: 1,564.99
Dividends reinvested/share: $2.80
Total return: -67.29%
Average Annual Total Return: -12.98%
Starting investment: $10,000.00
Ending investment: $3,271.92
Years: 8.04
 
Growth of $10,000.00
Without Dividends Reinvested

Start date: 03/10/2014
End date: 03/21/2022
Start price/share: $7.57
End price/share: $2.09
Dividends collected/share: $2.80
Total return: -35.40%
Average Annual Total Return: -5.29%
Starting investment: $10,000.00
Ending investment: $6,461.39
Years: 8.04
Date Ratio
11/22/20191115 for 1000
REPH is categorized under the Healthcare sector; below are some other companies in the same sector that also have a history of stock splits:

RGLS Split History
RHE Split History
RMD Split History
RMTI Split History
RNN Split History
RNVA Split History
ROCM Split History
ROKA Split History
ROSG Split History
RPTP Split History

Also explore: REPH shares outstanding history

Email EnvelopeFree REPH Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts

Liminal BioSciences Inc. (LMNL)
Galway Metals Inc. (GWM.CA)
Lannett Company, Inc. (LCI)
Reed's, Inc. (REED)
Phio Pharmaceuticals Corp. (PHIO)
Swvl Holdings Corp (SWVL)
Sientra, Inc. (SIEN)
Eargo, Inc. (EAR)
Alterity Therapeutics Limited (ATHE)
Aytu BioPharma, Inc. (AYTU)
More latest stock splits »
Latest mega mergers »
Latest stock buybacks »

REPH Insider Buying

REPH Split History | www.SplitHistory.com | Copyright © 2013 - 2023, All Rights Reserved

Nothing in www.SplitHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.